Dr Andrew Carnell graduated with a PhD (1991) at the University of Exeter on the enzymatic Baeyer Villiger oxidation. After a postdoc in Montreal, he worked in industry before being appointed lecturer at Liverpool in 1996. He currently serves on the Management Boards of CoEBio3 at Manchester, the European Federation of Biotechnology Biobased Materials Division and the Industrial Biotechnology Innovation Catalyst (IBIC).

Our research centres on the discovery and development of enzyme biocatalysts for the sustainable synthesis of bioplastics, biosurfactants and pharmaceuticals. We collaborate extensively with industry and with Research Council funding developed enzymes for a patented process for conversion of biomass-derived material into a sustainable bioplastics intermediate.